Moderna
MRNA
643 hedge funds and large institutions have $7.12B invested in Moderna in 2025 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 200 increasing their positions, 230 reducing their positions, and 90 closing their positions.
5% less funds holding
Funds holding: 674 → 643 (-31)
4.77% less ownership
Funds ownership: 75.49% → 70.71% (-4.8%)
12% less capital invested
Capital invested by funds: $8.06B → $7.12B (-$940M)
12% less call options, than puts
Call options by funds: $1.17B | Put options by funds: $1.33B
13% less repeat investments, than reductions
Existing positions increased: 200 | Existing positions reduced: 230
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
24% less first-time investments, than exits
New positions opened: 68 | Existing positions closed: 90
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$58.9M |
| 2 |
Morgan Stanley
New York
|
+$51.8M |
| 3 |
Charles Schwab
San Francisco,
California
|
+$35.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$31.1M |
| 5 |
Squarepoint
New York
|
+$29.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$205M |
| 2 |
Voloridge Investment Management
Jupiter,
Florida
|
-$67.9M |
| 3 |
Jane Street
New York
|
-$67M |
| 4 |
D.E. Shaw & Co
New York
|
-$36.7M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$34.3M |
MRNA Hedge Fund Activity: Q3 2025 in Review
643 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q3 2025, worth a combined $7.12B — down 12% from $8.06B a quarter earlier.
Sellers outnumbered buyers: 90 funds closed out of MRNA and 68 opened new positions — a net loss of 22 holders — while 230 trimmed existing stakes and 200 added.
The largest buyer was National Bank of Canada, adding an estimated $58.9M. The largest seller was Fidelity Investments, cutting an estimated $205M.
- 643 institutional investors held Moderna (MRNA) as of Q3 2025, down from 674 in Q2 2025.
- Funds reported $7.12B of Moderna stock for Q3 2025, down 12% quarter-over-quarter.
- 68 funds opened new Moderna positions in Q3 2025 and 90 closed out, a net change of -22 holders.
- The largest Moderna buyer in Q3 2025 was National Bank of Canada, an estimated $58.9M added.
- The largest Moderna seller in Q3 2025 was Fidelity Investments, an estimated $205M sold.
Based on aggregated 13F filings for Q3 2025.